M. Collins

发表

Cationic Liposomes Enhance the Rate of Transduction by a Recombinant Retroviral Vector In Vitro and In Vivo

C. Porter, G. Box, K. Lukacs, 1998, Journal of Virology.

Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery

Y. Takeuchi, M. Collins, Altar M. Munis, 2019, Molecular therapy. Nucleic acids.

Characterisation of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins

Y. Takeuchi, M. Collins, Altar M. Munis, 2018, bioRxiv.

Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes

Y. Takeuchi, M. Collins, Altar M. Munis, 2018, Molecular therapy. Methods & clinical development.

Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins

Y. Takeuchi, M. Collins, Altar M. Munis, 2018, Journal of Virology.

Human Immunodeficiency Virus Type 1 Vectors with Alphavirus Envelope Glycoproteins Produced from Stable Packaging Cells

Y. Ikeda, Y. Takeuchi, J. Richter, 2005, Journal of Virology.

Sensitization of cells and retroviruses to human serum by (αl-3) galactosyltransferase

C. Porter, F. Cosset, R. Weiss, 1996, Nature.

Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase.

C. Porter, F. Cosset, R. Weiss, 1996, Nature.

Retrovirus Targeting by Tropism Restriction to Melanoma Cells

F. Cosset, S. Neil, F. Martin, 1999, Journal of Virology.

The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite.

C. Springer, J. Bridgewater, M. Collins, 1997, Human gene therapy.

Gene transfer to repopulating human CD34+cells using amphotropic or RD114 pseudotyped HIV-1 based vectors from permanent producer cell lines (STAR)

Yasuhiro Takeuchi, Karin Olsson, Thomas Relander, 2003 .

Tubulovesicular Structures within Vesicular Stomatitis Virus G Protein-Pseudotyped Lentiviral Vector Preparations Carry DNA and Stimulate Antiviral Responses via Toll-Like Receptor 9

A. Pichlmair, Y. Ikeda, Y. Takeuchi, 2006, Journal of Virology.

Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.

B. Chain, Y. Ikeda, M. Zenke, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Long-term expression from non-integrating lentiviral vectors in muscle

Nj Ward, Luis Apolonia, Gerben Bouma, 2007 .

Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer

M. Collins, M. Perro, D. Hart, 2010, Gene Therapy.

Spontaneous Heteromerization of Gammaretrovirus Envelope Proteins: a Possible Novel Mechanism of Retrovirus Restriction

M. Collins, M. Dewannieux, 2008, Journal of Virology.

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells

Clare L. Bennett, K. Karwacz, M. Collins, 2011, EMBO molecular medicine.

Lentiviral Vectors for TCR Gene Transfer: Improved Function of TCR-Transduced T Cells After Non-Activating Cytokine-Mediated Transduction

Emma Morris, Daniel P. Hart, Hans J. Stauss, 2010 .

Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization.

B. Chain, M. Collins, Helen M Rowe, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Insertional Gene Activation by Lentiviral and Gammaretroviral Vectors

I. Robinson, Y. Takeuchi, M. Collins, 2008, Journal of Virology.

Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections

R. Weiss, Y. Takeuchi, M. Collins, 1993, Journal of virology.

Development of non-integrating lentiviral vectors

Luis Apolonia, Aj Thrasher, Simon N. Waddington, 2006 .

Escape from R-peptide deletion in a γ-retrovirus.

K. Cichutek, M. Collins, C. Buchholz, 2011, Virology.

Lentiviral vectors targeted to MHC II are effective in immunization.

M. Collins, C. Buchholz, A. Ageichik, 2011, Human gene therapy.

A lentiviral vector pseudotype suitable for vaccine development

Y. Takeuchi, M. Collins, M. Dewannieux, 2011, The journal of gene medicine.

Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8+ and CD4+ T-Cell Responses

V. Cerundolo, Y. Ikeda, M. Collins, 2007, Journal of Virology.

Intravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response1

V. Cerundolo, Y. Ikeda, M. Collins, 2004, The Journal of Immunology.

Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies

B. Chain, J. Greenwood, M. Collins, 2011, Cancer Immunology, Immunotherapy.

Envelope-targeted retrovirus vectors transduce melanoma xenografts but not spleen or liver.

S. Neil, M. Collins, Neil Phillipps, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses.

R. Vile, R. Weiss, Y. Takeuchi, 1992, Virology.

DNA fusion vaccine designs to induce tumor‐lytic CD8+ T‐cell attack via the immunodominant cysteine‐containing epitope of NY‐ESO 1

M. Collins, J. Rice, F. Stevenson, 2013, International journal of cancer.

CTL Response Encoding NY-ESO-1 Induces an Effective Intravenous Injection of a Lentiviral Vector

V. Cerundolo, Y. Ikeda, M. Collins, 2004 .

In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice.

A. Galy, M. Collins, S. Ciré, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7

K. Karwacz, M. Collins, K. Breckpot, 2010, Journal of Virology.

Kaposi's Sarcoma-Associated Herpesvirus vFLIP and Human T Cell Lymphotropic Virus Type 1 Tax Oncogenic Proteins Activate IκB Kinase Subunit γ by Different Mechanisms Independent of the Physiological Cytokine-Induced Pathways

Y. Takeuchi, M. Noursadeghi, M. Collins, 2011, Journal of Virology.

Selective ERK Activation Differentiates Mouse and Human Tolerogenic Dendritic Cells, Expands Antigen-Specific Regulatory T Cells, and Suppresses Experimental Inflammatory Arthritis

K. Karwacz, M. Collins, K. Breckpot, 2011, Arthritis and rheumatism.

Single-chain antibodies that target lentiviral vectors to MHC class II on antigen-presenting cells.

W. Marasco, M. Collins, E. Verhoeyen, 2009, Human gene therapy.

Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy

Y. Ikeda, M. Collins, Luciene Lopes, 2006, Cancer Immunology and Immunotherapy.

Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8 (cid:1) and CD4 (cid:1) T-Cell Responses (cid:1)

V. Cerundolo, M. Collins, K. Ariizumi, 2007 .

Immunisation with a lentivector that targets tumour antigen expression to dendritic cells induces potent CD 8 + and CD 4 + T cell responses

V. Cerundolo, Y. Ikeda, M. Collins, 2007 .

Molecular Studies of the Human T-Cell Antigen Receptor

M. Collins, M. Owen, M. Dunne, 1985 .

Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.

G. Mufti, F. Farzaneh, P. Patel, 1997, Human gene therapy.

vFLIP from KSHV inhibits anoikis of primary endothelial cells

N. Field, M. Noursadeghi, M. Collins, 2008, Journal of Cell Science.

Organisation and Expression of Human T Cell Receptor Genes

S. John, M. Collins, M. Owen, 1986 .

Expression of vFLIP in a Lentiviral Vaccine Vector Activates NF-κB, Matures Dendritic Cells, and Increases CD8+ T-Cell Responses

P. Kaye, M. Collins, Helen M Rowe, 2008, Journal of Virology.

The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity.

Y. Takeuchi, Heba Saadeh, A. Thrasher, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

4-1BB Ligand Activates Bystander Dendritic Cells To Enhance Immunization in Trans

M. Collins, A. Hotblack, G. Britton, 2014, The Journal of Immunology.

Conjugation of Lentivirus to Paramagnetic Particles via Nonviral Proteins Allows Efficient Concentration and Infection of Primary Acute Myeloid Leukemia Cells

G. Mufti, D. Nesbeth, F. Farzaneh, 2005, Journal of Virology.

Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope.

F. Cosset, Y. Takeuchi, M. Collins, 1998, Human gene therapy.

Efficient retroviral vector targeting of carcinoembryonic antigen-positive tumors.

K. Chester, J. Bridgewater, M. Collins, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Inhibitors of Poly(ADP-Ribose) Polymerase Block the Infection of Mammalian Cells by Retroviral Vectors

F. Farzaneh, M. Collins, S. Shall, 1992 .

Targeted Retroviral Infection of Tumor Cells by Receptor Cooperation

F. Cosset, K. Chester, S. Neil, 2003, Journal of Virology.

Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease

W. Barclay, M. Collins, M. Maini, 2013, Mucosal Immunology.

Retroviral vectors for cancer gene therapy.

M. Collins, 2000, Ernst Schering Research Foundation workshop.

Cyclosporine Increases Human Immunodeficiency Virus Type 1 Vector Transduction of Primary Mouse Cells

Y. Ikeda, G. Towers, M. Collins, 2006, Journal of Virology.

Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954.

C. Springer, J. Bridgewater, M. Collins, 1995, European journal of cancer.

Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity

I. Giddings, V. Schreiber, J. Ménissier-de murcia, 1996, Journal of virology.

High-titer packaging cells producing recombinant retroviruses resistant to human serum

Y Takeuchi, F. Cosset, R. Weiss, 1995, Journal of virology.

One Contribution to the Special Feature 'evolution and Genetics in Medicine' Guest Edited Gene Therapy: Progress and Predictions

Mary Collins, B. Spratt, A. Thrasher, 2022 .

Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus

Y Takeuchi, R. Vile, R. Weiss, 1992, Journal of virology.

Enhancing the purification of Lentiviral vectors for clinical applications

Mary Collins, Paula M. Alves, Cristina Peixoto, 2021 .

Gene therapy meets vaccine development.

Vincenzo Cerundolo, V. Cerundolo, M. Collins, 2004, Trends in biotechnology.

Retroviral retargeting by envelopes expressing an N-terminal binding domain

F. Cosset, R. Weiss, Y. Takeuchi, 1995, Journal of virology.

Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells.

Y. Ikeda, Y. Takeuchi, J. Richter, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Targeting lentiviral vectors for cancer immunotherapy.

M. Collins, K. Breckpot, D. Escors, 2011, Current cancer therapy reviews.

Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell

Y Takeuchi, F. Cosset, R. Weiss, 1994, Journal of virology.

Postentry Restriction to Human Immunodeficiency Virus-Based Vector Transduction in Human Monocytes

Y. Ikeda, S. Neil, M. Collins, 2001, Journal of Virology.

Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes

M. Collins, C. Selden, D. Escors, 2007, The journal of gene medicine.

A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene.

R. Vile, R. Weiss, T. Schulz, 1991, Virology.

Dynamic Interaction between the Dual Specificity Phosphatase MKP7 and the JNK3 Scaffold Protein β-Arrestin 2*

M. Collins, Emma A Willoughby, 2005, Journal of Biological Chemistry.

The JNK-interacting Protein-1 Scaffold Protein Targets MAPK Phosphatase-7 to Dephosphorylate JNK*

A. Whitmarsh, M. Collins, G. R. Perkins, 2003, The Journal of Biological Chemistry.

Abrogation of Ref1 Retrovirus Restriction in Human Cells

Y. Takeuchi, G. Towers, M. Collins, 2002, Journal of Virology.

Stable gene transfer to muscle using non-integrating lentiviral vectors.

Luis Apolonia, Gerben Bouma, N. Philpott, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Murine Leukemia Virus Particle Assembly Quantitated by Fluorescence Microscopy: Role of Gag-Gag Interactions and Membrane Association

Y. Takeuchi, M. Collins, L. Hewlett, 2003, Journal of Virology.

Construction of stable packaging cell lines for clinical lentiviral vector production

J. Minshull, Y. Takeuchi, A. Thrasher, 2015, Scientific Reports.

Continuous high-titer HIV-1 vector production

F. Cosset, Y. Ikeda, Y. Takeuchi, 2003, Nature Biotechnology.

Lentiviral vector followed by protein immunisation breaks tolerance against the self‐antigen Her1 and results in lung cancer immunotherapy

K. Karwacz, M. Collins, Y. A. Alpizar, 2012, The journal of gene medicine.

Targeting dendritic cell signaling to regulate the response to immunization.

S. Akira, J. Hiscott, M. Collins, 2008, Blood.

Immunization of Mice with Lentiviral Vectors Targeted to MHC Class II+ Cells Is Due to Preferential Transduction of Dendritic Cells In Vivo

A. Galy, Roseline Yao, M. Collins, 2014, PloS one.

DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant.

F. Cosset, D. Klatzmann, B. Bellier, 2006, Vaccine.

Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity

Y. Takeuchi, M. Collins, P. Risley, 2020, Frontiers in Immunology.

Safer, Silencing-Resistant Lentiviral Vectors: Optimization of the Ubiquitous Chromatin-Opening Element through Elimination of Aberrant Splicing

Y. Takeuchi, M. Grez, A. Thrasher, 2012, Journal of Virology.

Lentiviral expression of GAD67 and CCK promoter‐driven opsins to target interneurons in vitro and in vivo

D. Kullmann, S. Schorge, M. Collins, 2016, The journal of gene medicine.

Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectors

R. Thorpe, Y. Takeuchi, M. Collins, 2018, Biologicals : journal of the International Association of Biological Standardization.

Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette–Guérin challenge in mice

M. Collins, Jeremy S. Brown, A. Goodman, 2015, Immunology.

The JNK phosphatase M3/6 is inhibited by protein-damaging stress

M. Collins, G. R. Perkins, C. Palacios, 2001, Current Biology.

Nonintegrating Lentivector Vaccines Stimulate Prolonged T-Cell and Antibody Responses and Are Effective in Tumor Therapy

K. Karwacz, A. Thrasher, M. Collins, 2009, Journal of Virology.

Effect of the Internal Promoter on Insertional Gene Activation by Lentiviral Vectors with an Intact HIV Long Terminal Repeat

Y. Takeuchi, M. Collins, Marieke Bokhoven, 2010, Journal of Virology.

Effect of the Internal Promoter on Insertional Gene Activation by Lentiviral Vectors with an Intact HIV Long Terminal Repeat

Y. Takeuchi, M. Collins, Marieke Bokhoven, 2010, Journal of Virology.

Gene transfer to repopulating human CD34+cells using amphotropic, GALV or RD114 pseudotyped HIV-1 based vectors from stable producer cells.

Y. Ikeda, Y. Takeuchi, J. Richter, 2004 .

Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis.

Y. Takeuchi, M. Collins, S. Knight, 2013, Current gene therapy.

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma.

R. Rees, M. Gore, J. Kirkwood, 1999, Human gene therapy.

Nonintegrating Lentivector Vaccines Stimulate Prolonged T-Cell and Antibody Responses and Are Effective in Tumor Therapy

K. Karwacz, A. Thrasher, M. Collins, 2009, Journal of Virology.

Insertional Gene Activation by Lentiviral and Gammaretroviral Vectors

I. Robinson, Y. Takeuchi, M. Collins, 2008, Journal of Virology.

Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization.

Helen M. Rowe, B. Chain, M. Collins, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

One Contribution to the Special Feature 'evolution and Genetics in Medicine' Guest Edited Gene Therapy: Progress and Predictions

B. Spratt, A. Thrasher, M. Collins, 2022 .

Safer, Silencing-Resistant Lentiviral Vectors: Optimization of the Ubiquitous Chromatin-Opening Element through Elimination of Aberrant Splicing

Y. Takeuchi, M. Grez, A. Thrasher, 2012, Journal of Virology.

Lentivector targeting to dendritic cells.

M. Collins, M. Dewannieux, A. Ageichik, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.